GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Embla Medical hf EMBLA.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

28.20

+0.89%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$963.6m

FY2016FY2025

Net income

$86.5m

FY2016FY2025

Free cash flow

$118.9m

FY2016FY2025

Shareholders' equity

$888.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$963.6m$854.9m$799.1m$718.6m$718.7m$629.5m$686.3m$612.9m$568.6m$520.7m
Gross profit$560.6m$534.7m$485.6m$439.7m$455.4m$391.2m$438.6m$386.8m$354.8m$328.4m
Research and development$41.0m$40.8m$38.1m$34.0m$31.7m$31.0m$31.3m$31.4m$28.9m$23.2m
Operating income$129.4m$113.8m$89.4m$67.1m$95.6m$53.3m$99.2m$90.5m$80.5m$72.2m
Net income$86.5m$68.3m$58.4m$42.5m$64.0m$6.2m$66.0m$79.8m$57.6m$51.0m
Diluted earnings per share0.200.170.140.100.160.020.170.200.130.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.74bn$1.54bn$1.39bn$1.33bn$1.25bn$1.21bn$1.09bn$913.6m$793.0m$746.4m
Cash and short-term investments$102.3m$86.2m$72.7m$76.6m$85.2m$102.4m$58.6m$55.7m$37.3m$35.1m
Total liabilities$848.7m$758.3m$680.7m$689.9m$620.3m$637.1m$521.7m$376.0m$292.6m$279.2m
Debt$541.6m$499.8m$467.7m$480.9m$448.2m$483.4m$360.2m$235.5m$158.7m$154.5m
Shareholders' equity$888.6m$777.2m$701.9m$635.7m$621.6m$572.5m$564.4m$534.5m$499.9m$466.4m
Shares outstanding428m414m420m423m398m412m391m408m428m433m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$141.8m$116.1m$94.3m$60.8m$100.5m$92.2m$95.3m$69.4m$73.9m$66.3m
Capital spending−$22.9m−$39.2m−$42.3m−$25.9m−$26.7m−$24.0m−$31.9m−$30.9m−$19.2m−$24.6m
Free cash flow$118.9m$76.8m$52.0m$34.8m$73.8m$68.2m$63.4m$38.6m$54.7m$41.7m
Dividends paid—————−$9.3m−$9.1m−$9.2m−$7.3m−$7.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$258.6m$228.6m$256.7m$237.6m$232.4m$202.8m$224.8m$213.5m
Gross profit$164.0m$130.2m$149.5m$138.3m$144.5m$127.8m$142.1m$133.6m
Operating income$41.6m$22.3m$36.8m$37.4m$33.3m$21.9m$32.0m$32.6m
Net income$29.2m$14.2m$24.4m$25.9m$20.9m$12.2m$18.2m$21.9m
Diluted earnings per share0.070.030.060.060.050.030.040.05
Cash from operations$37.0m$9.0m$53.0m$48.0m$22.0m$13.0m$41.0m$41.0m
Capital spending−$5.0m−$3.0m−$5.0m−$5.0m−$10.0m−$6.0m−$8.0m−$8.0m
Free cash flow$32.0m$6.0m$48.0m$43.0m$12.0m$7.0m$33.0m$33.0m
Total assets$1.72bn$1.71bn$1.74bn$1.72bn$1.68bn$1.59bn$1.54bn$1.58bn
Cash and short-term investments$98.8m$93.6m$102.3m$101.9m$95.2m$93.2m$86.2m$81.2m
Debt$387.4m$401.2m$387.9m$51.1m$420.2m$399.9m$381.5m$423.2m
Shareholders' equity$920.6m$898.4m$888.6m$865.9m$832.1m$798.1m$777.2m$783.9m

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin58.2%62.5%60.8%61.2%63.4%62.1%
Operating margin13.2%13.3%11.8%9.4%13.3%8.5%
Net margin9.0%8.0%7.3%5.9%8.9%1.0%
Return on equity9.7%8.8%8.3%6.7%10.3%1.1%
Return on assets5.0%4.4%4.2%3.2%5.1%0.5%
Free cash flow yield1.4%1.4%1.2%0.8%1.2%1.0%
Revenue growth12.7%7.0%11.2%-0.0%14.2%-8.3%
Earnings growth26.6%16.9%37.3%-33.6%929.8%-90.6%
Current ratio1.48x1.90x1.92x1.47x1.71x2.22x
Debt to equity0.44x0.49x0.51x0.57x0.53x0.66x
Equity ratio51.0%50.5%50.7%48.0%49.8%47.1%
Interest coverage5.80x4.90x5.23x6.01x9.76x5.54x
R&D as a share of sales4.3%4.8%4.8%4.7%4.4%4.9%
Buybacks as a share of market value-3.4%1.5%0.5%-6.1%3.4%-5.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.3%8.9%7.1%
Operating income24.4%19.4%5.3%
Net income26.7%69.3%5.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin60.2%60.6%61.2%61.9%
Operating margin13.4%12.0%11.7%12.8%
Net margin8.5%7.7%7.0%8.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings24.933.430.651.640.7497.547.924.630.633.1
Price to sales2.22.72.23.03.64.94.63.23.13.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 13 Mar 2020.

FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Paid in the year0.150.140.130.120.120.120.100.10

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.